Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
June 2014, Part 2
Nivolumab, a Novel Anti–PD-1 Monoclonal Antibody for the Treatment of Solid and Hematologic Malignancies
By
Emma Thornton
Immunotherapy
Read More ›
Immuno-Oncology Takes Center Stage
By
Lisa Raedler, PhD, RPh
Immunotherapy
Read More ›
Immune-Related Endocrinopathies Associated with Ipilimumab Therapy
By
Le Min, MD, PhD
Immunotherapy
Read More ›
Immunotherapy Holds Promise to Extend Survival in GI Cancers
By
Wayne Kuznar
Gastrointestinal Cancer
Read More ›
IDO: A Target for Cancer Treatment
By
Beverly E Barton, PhD
Editorial
Read More ›
The Treatment of Relapsed Metastatic Melanoma Using a Novel Immunotherapy Combination:
An Interview with Mario Sznol, MD
By
Lisa Raedler, PhD, RPh
Interview with the Innovators
Read More ›
Oncolytic Viruses for the Treatment of Advanced Melanoma
By
Beverly E Barton, PhD
Melanoma/Skin Cancer
Read More ›